Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms.

ABSTRACT: Glioblastoma (GBM) is the most typical and aggressive form of primary brain tumor in adults, with a poor prognosis. Successful glioma treatment is hampered by ineffective medication distribution across the blood-brain barrier (BBB) and the emergence of drug resistance. Although a few FDA-approved multimodal treatments are available for glioblastoma, most patients still have poor prognoses. Targeting epigenetic variables, immunotherapy, gene therapy, and different vaccine- and peptide-based treatments are some innovative approaches to improve anti-glioma treatment efficacy. Following the identification of lymphatics in the central nervous system, immunotherapy offers a potential method with the potency to permeate the blood-brain barrier. This review will discuss the rationale, tactics, ben

SUBMITTER: Karami Fath M 

PROVIDER: S-EPMC9501259 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature